跳至主要内容
临床试验/NCT05981898
NCT05981898已完成不适用

An Advanced Decision Tool Opt-IVf for Personalized Medicine for IVF Using Modeling and Optimization

Stochastic Research Technologies LLC1 个研究点 分布在 1 个国家目标入组 550 人开始时间: 2023年9月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
550
试验地点
1
主要终点
Number of Mii Follicles

研究概览

简要总结

A multi-center randomized clinical trial is proposed to study the effectiveness of the advanced decision support tool Opt-IVF for ALL PROTOCOLS in reducing medication, testing, and improving outcomes.

详细描述

Aim: A Multi-center Randomized Clinical trial to determine the effectiveness of using the proposed decision support tool for ALL PROTOCOLS for each patient's customized optimal drug dosage profile.

Subject Enrollment

There are 13 centers involved in this trial. The recruitment plan designed is study-specific and site-specific. The investigators plan to recruit patients by reaching into the each center's own database of patients. Each center carries out on average 800 IVF cycles per year. PIs anticipate easier recruitment since they are not excluding any IVF patients, whether they are low, high, or average responders undergoing any protocol or patients with PCOS or not. The in-reach activities to be used include:

Chart review from site patient database Establishing an internal referral network with all physicians within the site Educational meetings with providers and physicians Educational sessions with patients and relatives Financial assistance to patients undergoing the intervention Training staff to facilitate ICF process by o Effectively conveying risks and benefits Creating an open environment Monthly calls to site physicians and staff to convey success stories

The retention activities include:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

盲法说明

The investigator and outcomes assessor Dr. Urmila Diwekar will only know the de-identified patient details in each arm after the treatment.

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Inclusion Criteria:
  • • All-female patients undergoing IVF with own oocyte

排除标准

  • 未提供

结局指标

主要结局

Number of Mii Follicles

时间窗: at the end of cycle (each cycle is 17 days)

Number of Mii Follicles

Number of Grade A embryos

时间窗: at the end of cycle (each cycle is 17 days)

Number of Grade A embryos

Number of Follicles retrieved

时间窗: at the end of cycle (each cycle is 17 days)

Mature follicles retrieved

Clinical Pregnancy Rate

时间窗: One month after implantation

Clinical Pregnancy Rate

Total number of Embryos

时间窗: at the end of cycle (each cycle is 17 days)

Total number of Embryos

Total FSH+HMG Dosage in IUI for the complete cycle

时间窗: at the end of cycle (each cycle is 17 days)

Total FSH+HMG Dosage in IUI for the complete cycle

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验